After studying the economic viability of O3MET, and considering the commercial strategy described in our business plan, we foresee sales of 940 units to farmers and a 5% market uptake for O3MET in the five years post-market launch (2019-2023), with an accumulated turnover of €54 million and €10.1 million net profit for the SME MET. Beyond boosting MET business growth, O3MET intends to become a universal solution feasible for virtually any pathogen/disease in European greenhouses that (if consolidated as a routine technology) might reach European market sizes in the order of magnitude of biopesticides (€1.5 billion) but without the technical drawbacks of those. Once fully developed technically and commercially during a phase 2 project, O3MET will consolidate in its home market (Italy), and will progressively expand to the main producers in the Mediterranean (Spain, Morocco, Turkey, Israel, Tunisia, France) and EU (Netherlands) to be able to internationalize to non-EU markets later on (America –USA, Mexico, Chile-, South Africa, and Asia-Oceania –India, China, Australia -).
If, under optimistic market conditions, O3MET could be installed in just 25% of the European greenhouse tomato production (25,000 ha), European agriculture would benefit in €70 million, including savings in pesticides (€38 million) and savings in work time of greenhouse operators (€31 million). Ultimately, the innovative OMET technology will drastically increase the efficiency in food production and storage throughout all the value chain. It will prevent and minimize diseases in greenhouse crop production and will boost a remarkable extension in the shelf life of vegetables, providing an eco-friendly (residue-free) Integrated Pest Management solution fully compliant with European Union trends promoting a reduced use of chemical phytosanitary products while ensuring safety for agricultural workers and food consumers.